Primary study · included by 2 reviews
Impact of autogenous concentrated bone marrow aspirate on bone regeneration after sinus floor augmentation with a bovine bone substitute--a split-mouth pilot study.
Wildburger 2014 · Wildburger Angelika, Payer Michael, Jakse Norbert, et al. · Clinical oral implants research · 2014
Included by
| Outcome this study informs | Pooled effect | Evidence | Certainty |
|---|---|---|---|
Bone regeneration success (presence or absence of new bone formation, dichotomous) Mesenchymal stem cell (MSC)-based bone regeneration (MSC with biomaterial or cellular allograft) vs Bone regeneration without stem cells (e.g., biomaterial or autograft alone, blood clot, particulate allograft) | RR 1.16 [0.70, 1.93] | 2 studies | GRADE not reported |
Implant success rate Mesenchymal stem cell (MSC)-based bone regeneration (MSC with biomaterial or cellular allograft) vs Bone regeneration without stem cells (e.g., biomaterial or autograft alone, blood clot, particulate allograft) | log RR -0.03 [-0.09, 0.04] | 4 studies | GRADE not reported |
Bone regeneration success (presence or absence of new bone formation, dichotomous) Mesenchymal stem cell (MSC)-based bone regeneration (MSC with biomaterial or cellular allograft) vs Bone regeneration without stem cells (e.g., biomaterial or autograft alone, blood clot, particulate allograft) | RR 1.22 [0.73, 2.04] | 2 studies | GRADE not reported |
Implant success rate Mesenchymal stem cell (MSC)-based bone regeneration (MSC with biomaterial or cellular allograft) vs Bone regeneration without stem cells (e.g., biomaterial or autograft alone, blood clot, particulate allograft) | log RR -0.03 [-0.10, 0.04] | 4 studies | GRADE not reported |
Implant success rate Mesenchymal stem cell (MSC)-based bone regeneration (MSC with biomaterial or cellular allograft) vs Bone regeneration without stem cells (e.g., biomaterial or autograft alone, blood clot, particulate allograft) · Follow-up 3 to 12 months | RR 0.98 [0.94, 1.03] | 5 studies · 222 implants participants | Moderate |
Implant success rate Mesenchymal stem cell (MSC)-based bone regeneration (MSC with biomaterial or cellular allograft) vs Bone regeneration without stem cells (e.g., biomaterial or autograft alone, blood clot, particulate allograft) | log RR -0.01 [-0.06, 0.03] | 4 studies | GRADE not reported |
Implant success rate Mesenchymal stem cell (MSC)-based bone regeneration (MSC with biomaterial or cellular allograft) vs Bone regeneration without stem cells (e.g., biomaterial or autograft alone, blood clot, particulate allograft) | log RR -0.03 [-0.10, 0.04] | 4 studies | GRADE not reported |
Bone regeneration success (presence or absence of new bone formation, dichotomous) Mesenchymal stem cell (MSC)-based bone regeneration (MSC with biomaterial or cellular allograft) vs Bone regeneration without stem cells (e.g., biomaterial or autograft alone, blood clot, particulate allograft) | RR 1.03 [0.63, 1.69] | 2 studies | GRADE not reported |
Implant success rate Mesenchymal stem cell (MSC)-based bone regeneration (MSC with biomaterial or cellular allograft) vs Bone regeneration without stem cells (e.g., biomaterial or autograft alone, blood clot, particulate allograft) | log RR -0.00 [-0.05, 0.04] | 4 studies | GRADE not reported |
Bone regeneration success (presence or absence of new bone formation, dichotomous) Mesenchymal stem cell (MSC)-based bone regeneration (MSC with biomaterial or cellular allograft) vs Bone regeneration without stem cells (e.g., biomaterial or autograft alone, blood clot, particulate allograft) | RR 1.11 [0.73, 1.67] | 3 studies | High |
The review does not say which of its outcomes this study informs.
2 including reviews in total.